TLR7 and neoplasm: This platform was composed of a photosensitizer chlorin e6 (Ce6), and a toll-like receptor-7 (TLR-7) agonist (imiquimod (R837)) as the immune adjuvant, together with aCTLA-4 was able to target tumor growth effectively.